ROYAL LONDON ASSET MANAGEMENT LTD - IMPAX LABORATORIES INC ownership

Quarter-by-quarter ownership
ROYAL LONDON ASSET MANAGEMENT LTD ownership history of IMPAX LABORATORIES INC
ValueSharesWeighting
Q2 2016$1,773,000
-46.1%
61,506
-18.4%
0.03%
-43.1%
Q4 2015$3,287,000
+37.2%
75,383
+10.8%
0.05%
+30.8%
Q3 2015$2,395,000
-90.0%
68,027
-8.9%
0.04%
-13.3%
Q4 2014$23,915,000
+1405.0%
74,700
+14.4%
0.04%
+12.5%
Q3 2014$1,589,000
+1.1%
65,3000.0%0.04%
+11.1%
Q2 2014$1,571,000
+2.2%
65,300
+13.4%
0.04%0.0%
Q1 2014$1,537,00057,6000.04%
Other shareholders
IMPAX LABORATORIES INC shareholders Q3 2023
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 560,400$9,022,0003.93%
NORTH TIDE CAPITAL, LLC 1,000,000$16,100,0003.58%
Sivik Global Healthcare LLC 250,000$4,025,0001.47%
MAVERICK CAPITAL LTD 7,159,336$115,265,0001.44%
SECTOR GAMMA AS 589,311$9,488,0001.38%
BRIDGER MANAGEMENT, LLC 1,341,143$21,592,0001.23%
Eos Focused Equity Management, L.P. 48,714$784,0000.89%
Bridge City Capital, LLC 47,194$760,0000.64%
Fosun International Ltd 300,000$4,830,0000.60%
Century Capital Management, LLC 203,138$3,271,0000.56%
View complete list of IMPAX LABORATORIES INC shareholders